[go: up one dir, main page]

PE17098A1 - Nuevas sulfonamidas - Google Patents

Nuevas sulfonamidas

Info

Publication number
PE17098A1
PE17098A1 PE1996000714A PE00071496A PE17098A1 PE 17098 A1 PE17098 A1 PE 17098A1 PE 1996000714 A PE1996000714 A PE 1996000714A PE 00071496 A PE00071496 A PE 00071496A PE 17098 A1 PE17098 A1 PE 17098A1
Authority
PE
Peru
Prior art keywords
formula
phenyl substituted
substituted
refers
compounds
Prior art date
Application number
PE1996000714A
Other languages
English (en)
Inventor
Marcel Muller
Bernd-Michael Loffler
Kaspar Burri
Volker Breu
Henri Ramuz
Jean-Marie Cassal
Martine Clozel
Georges Hirth
Werner Neidhart
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE17098A1 publication Critical patent/PE17098A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIEREN A COMPUESTOS DE FORMULA (I), EN DONDE: "X" e "Y" SON OXIGENO o AZUFRE; "Z" ES H, ALQUILO INFERIOR O ARILO, ENTRE OTROS; Ra PREFERENTEMENTE ES H o OH; Rb PREFERENTEMENTE ES H; n ES 0 o 1; "A" ES C(O)R3, EN DONDE R3 ES OH, ALCOXILO INFERIOR O -NR4R5, EN DONDE: R4 PREFERENTEMENTE ES H, Y R5 PREFERENTEMENTE ES TETRAZOLILO; R1 PREFERENTEMENTE ES FENILO SUSTITUIDO CON 4-TERC-BUTIL o 4-METOXI O ES PIRIDINO SUSTITUIDO CON 5-ISOPROPIL; R2 ES FENILO SUSTITUIDO CON METOXI O HALOGENO. TAMBIEN SE REFIERE AL COMPUESTO INTERMEDIO DE FORMULA (II), EN DONDE: "A" ES FORMILO o FURAN-2-ILO. ADEMAS SE REFIERE AL PROCEDIMIENTO DE PREPARACION DE (I). LOS COMPUESTOS OBTENIDOS ACTUAN COMO INHIBIDORES DEL RECEPTOR DE LA ENDOTELINA, UTILES EN EL TRATAMIENTO DE TRANSTORNOS CIRCULATORIOS TALES COMO HIPERTENSION, ISQUEMIA, VASOESPASMOS Y ANGINA PECTORIS
PE1996000714A 1995-10-12 1996-10-09 Nuevas sulfonamidas PE17098A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH289395 1995-10-12

Publications (1)

Publication Number Publication Date
PE17098A1 true PE17098A1 (es) 1998-04-15

Family

ID=4243971

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1996000714A PE17098A1 (es) 1995-10-12 1996-10-09 Nuevas sulfonamidas

Country Status (28)

Country Link
US (1) US5856484A (es)
EP (1) EP0768304B1 (es)
JP (1) JP2723496B2 (es)
CN (1) CN1115339C (es)
AR (1) AR004215A1 (es)
AT (1) ATE217867T1 (es)
AU (1) AU706748B2 (es)
BR (1) BR9605046B1 (es)
CA (1) CA2187130C (es)
CO (1) CO4770959A1 (es)
CZ (1) CZ260596A3 (es)
DE (1) DE59609225D1 (es)
DK (1) DK0768304T3 (es)
ES (1) ES2175006T3 (es)
HU (1) HUP9602748A3 (es)
IL (1) IL119371A (es)
MA (1) MA23980A1 (es)
MX (1) MX9604762A (es)
NO (1) NO308000B1 (es)
NZ (1) NZ299519A (es)
PE (1) PE17098A1 (es)
PL (1) PL316486A1 (es)
PT (1) PT768304E (es)
SG (1) SG46753A1 (es)
TR (1) TR199600778A2 (es)
TW (1) TW438779B (es)
UY (1) UY24346A1 (es)
ZA (1) ZA968451B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ260596A3 (en) * 1995-10-12 1997-12-17 Hoffmann La Roche Sulfonamide derivative, process of its preparation and pharmaceutical composition containing thereof
JP4058507B2 (ja) * 1997-07-10 2008-03-12 国立大学法人 東京医科歯科大学 ４，５−ジヒドロ−［１Ｈ］−ベンズ［ｇ］インダゾール−３−カルボン酸誘導体
US6191170B1 (en) 1998-01-13 2001-02-20 Tularik Inc. Benzenesulfonamides and benzamides as therapeutic agents
US6136971A (en) * 1998-07-17 2000-10-24 Roche Colorado Corporation Preparation of sulfonamides
CA2315614C (en) * 1999-07-29 2004-11-02 Pfizer Inc. Pyrazoles
CA2389479A1 (en) * 1999-12-22 2001-06-28 Christoph Boss Butyne diol derivatives
US6720322B2 (en) 1999-12-22 2004-04-13 Actelion Pharamceuticals Ltd. Butyne diol derivatives
AU2001265871A1 (en) * 2000-04-25 2001-11-07 Actelion Pharmaceuticals Ltd Substituted sulfonylaminopyrimidines
US6387915B2 (en) 2000-05-31 2002-05-14 Pfizer Inc. Isoxazole-sulfonamide endothelin antagonists
US6670362B2 (en) 2000-09-20 2003-12-30 Pfizer Inc. Pyridazine endothelin antagonists
US8463964B2 (en) * 2009-05-29 2013-06-11 Invensys Systems, Inc. Methods and apparatus for control configuration with enhanced change-tracking

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW270116B (es) * 1991-04-25 1996-02-11 Hoffmann La Roche
RU2086544C1 (ru) * 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
TW287160B (es) * 1992-12-10 1996-10-01 Hoffmann La Roche
TW394761B (en) * 1993-06-28 2000-06-21 Hoffmann La Roche Novel Sulfonylamino Pyrimidines
IL111959A (en) * 1993-12-17 2000-07-16 Tanabe Seiyaku Co N-(polysubstituted pyrimidin-4-yl) benzenesulfonamide derivatives their preparation and pharmaceutical compositions containing them
CZ260596A3 (en) * 1995-10-12 1997-12-17 Hoffmann La Roche Sulfonamide derivative, process of its preparation and pharmaceutical composition containing thereof

Also Published As

Publication number Publication date
NO964334D0 (no) 1996-10-11
MA23980A1 (fr) 1997-07-01
JPH09110840A (ja) 1997-04-28
BR9605046B1 (pt) 2010-08-10
CN1115339C (zh) 2003-07-23
PL316486A1 (en) 1997-04-14
CO4770959A1 (es) 1999-04-30
MX9604762A (es) 1997-04-30
AU6817296A (en) 1997-04-17
HU9602748D0 (en) 1996-11-28
US5856484A (en) 1999-01-05
BR9605046A (pt) 1998-06-30
ZA968451B (en) 1997-04-14
PT768304E (pt) 2002-10-31
AU706748B2 (en) 1999-06-24
DK0768304T3 (da) 2002-09-09
DE59609225D1 (de) 2002-06-27
CA2187130A1 (en) 1997-04-13
ATE217867T1 (de) 2002-06-15
SG46753A1 (en) 1998-02-20
NO308000B1 (no) 2000-07-03
ES2175006T3 (es) 2002-11-16
CA2187130C (en) 2006-10-03
CN1151400A (zh) 1997-06-11
EP0768304A1 (de) 1997-04-16
TW438779B (en) 2001-06-07
HUP9602748A2 (en) 1997-05-28
CZ260596A3 (en) 1997-12-17
NZ299519A (en) 1998-02-26
IL119371A0 (en) 1997-01-10
NO964334L (no) 1997-04-14
EP0768304B1 (de) 2002-05-22
IL119371A (en) 2001-04-30
JP2723496B2 (ja) 1998-03-09
TR199600778A2 (tr) 1997-04-22
UY24346A1 (es) 2001-03-16
AR004215A1 (es) 1998-11-04
HUP9602748A3 (en) 1998-04-28

Similar Documents

Publication Publication Date Title
PE17098A1 (es) Nuevas sulfonamidas
ATE145898T1 (de) Verwendung von sulfonamiden als heilmittel und neue sulfonamide
DE69528198D1 (de) Aryl-und hetaryl-sulfonamid derivate, deren herstellung und deren verwendung als endothelin-antagonisten
DE10299047I2 (de) Sulfonamide, ihre Herstellung und Verwendung als Heilmittel und Zwischenprodukte
NO872863L (no) AnalogifremgangsmŸte for fremstilling av terapeutiske imidazoler som blokkerer angiotensin-ii-reseptorer.
PE111299A1 (es) Derivados de n-aroilfenilalanina
ATE68495T1 (de) 4,5,6,7-tetrahydro-1h-imidazo(4,5c>pyridinderivate und analoge mit antihypertensiver wirkung.
DE69034103D1 (de) Imidazoalkensäure
PE20001419A1 (es) COMPLEJO DEL INHIBIDOR DE RAS-FARNESILTRANSFERASA Y SULFOBUTILETER-7-ß-CICLODEXTRINA O 2-HIDROXIPROPIL-ß-CICLODEXTRINA Y METODO
PE20020593A1 (es) Activadores de glucocinasa del tipo isoindolin-2-ona
FI811373L (fi) Substituerade fenyletrar
ES2159749T3 (es) Derivados de bencilamino-2-metil-propanamidas 2-(4-sustituidas).
FI905481A0 (fi) Substituerade n-(imidazolyl) -alkylalaninderivat.
ES2184083T3 (es) Derivados de acilaminoalquenilen-amida como antagonistas de nk1 y nk2.
FI852003A0 (fi) --laktamantibiotika, foerfarande foer deras framstaellning och deras anvaendning som laekemedel eller tillvaextbefraemjare vid boskapsuppfoedning eller som antioxidanter.
PE20020333A1 (es) Derivados de pirrolidina como inhibidores de la enzima conversor de endotelina
PE86698A1 (es) Derivados de indolina
PE16499A1 (es) Compuestos heterociclicos de guanidinilamino utiles como agonistas de alfa-2 adrenoreceptores
UY23428A1 (es) Procedimiento para la preparacion de nuevas sulfonamidas
NO872461L (no) Fremgangsmaate ved fremstilling av nye antihypertensive midler.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed